Stories

A study showed that vaping during pregnancy in rats led to weight gain, memory loss, behavioral changes, and premature aging in the offspring. Both e-liquid and nicotine impact development, causing health consequences from early development into adulthood. The study, conducted at West Virginia University, found that vaping resulted in cognitive impairment and negative effects on brain health, with e-liquid being a key factor in blood vessel impairment. Nicotine wasn't the sole factor in harm, as vaping without it still resulted in offspring damage. The study suggests that vaping poses similar cardiovascular risks as smoking, highlighting the need for caution, especially during pregnancy.

Juul Labs, tarnished by legal battles, aims for a comeback by focusing on adult smoking cessation with their new device, Juul2. Equipped with biometric safeguards and a companion app, the product targets smokers while restricting access for minors. Despite controversy and financial setbacks, investor James Sagan sees potential in Juul's resurgence. The company, once linked to youth vaping, faces regulatory challenges and mixed scientific opinions on its effectiveness. Embracing independence after Altria's exit, Juul's future hinges on Juul2's success in a competitive market. Sagan remains hopeful about Juul’s mission to address public health issues.

Swedish biotech firm Emplicure AB plans to seek U.S. approval for its quick-delivery nicotine system, Seratek, aiming to offer a more efficient smokeless alternative for adult users. Seratek released 80% of nicotine in five minutes, outperforming competitors in a recent study. Emplicure aims to file a PMTA for U.S. sales, with CEO Mattias Josander highlighting nicotine pouches as a potential public health breakthrough.

The UK has significantly reduced smoking rates by promoting vaping and safer nicotine alternatives, leading to a 166,000 decrease in premature deaths. This strategy has lowered smoking rates and improved health outcomes, with cardiovascular mortality down and fewer smoking-related hospital admissions. These results showcase the success of tobacco harm reduction. However, challenges such as potential restrictions on vaping products could slow progress. Countries like Sweden, Japan, and New Zealand have also seen success with harm reduction strategies. To continue this positive trend, it's crucial for the UK to defend the role of vaping and reduced-risk products. Global leadership in this area must be protected to benefit millions more.

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) has strongly criticized the Philippines’ new vape ban, calling it a “reckless policy” that removes safer alternatives for adult smokers. The ban on open pod systems and uncertified e-liquids has already closed compliant shops and limited consumer choices. Nancy Loucas, CAPHRA’s Executive Coordinator, argued that the government fails to distinguish between different vaping systems, demonstrating a lack of understanding that harms the public. CAPHRA also condemned the Department of Trade and Industry (DTI) for not consulting consumers, leading to policies that undermine effective public health measures.

A recent report questions the World Health Organization's independence due to significant donations by Bloomberg Philanthropies and undisclosed "dark money". The report highlights concerns over global health policies being influenced by donor-driven agendas, outlining instances where powerful financial interests, like Bloomberg, have shaped WHO's strategies, particularly in tobacco control. Transparency issues arise from the acceptance of undisclosed corporate funds by the WHO Foundation. Allegations point to Bloomberg's influence on public policy globally, bypassing democratic processes. The report urges reforms for accountability, inclusion of diverse voices, and respect for national sovereignty within the WHO's framework to prevent outside influences on health policies.

NGOs in Taiwan condemn a tobacco company for not labeling nicotine content on heated tobacco products, leading to their removal from shelves. Despite violating the law, the company opted for a fine over compliance. Authorities are investigating why the products differed from the approved samples. A study found high nicotine levels, surpassing legal limits. NGOs call for stricter enforcement, highlighting the company's power and profit in Taiwan's tobacco market. Health authorities clarify that heated tobacco's health risks are equivalent to regular cigarettes if nicotine levels exceed 1 milligram per stick. Tests are conducted on the products to verify compliance with regulations.

Italian Prime Minister Giorgia Meloni joked about potentially "killing someone" if she had to quit smoking during the Gaza peace summit in Egypt. She bantered with world leaders like Turkish President Erdogan, who urged her to quit. Meloni revealed she restarted smoking after 13 years. Despite President Trump's compliments on her appearance, Meloni has gained respect for her political success. As Italy's first female prime minister, she plays a crucial role in mediating between the EU and the US, notably during Ukraine war negotiations.

The ACT Government will increase enforcement against illegal smoking products through the Tobacco and Other Smoking Products Amendment Bill 2025. This bill aims to combat illicit tobacco and e-cigarettes by granting authorities new inspection and penalty powers. The reforms also enhance seizure provisions and officer safety measures. This initiative follows the alignment of vaping laws with federal regulations. Additionally, the government plans to provide substantial funding for smoking and vaping cessation support services. These measures signal a strong stance against illicit tobacco trading, emphasizing collaboration with other jurisdictions.

A peer-reviewed study in Marketing Science shows that direct-to-consumer ads for prescription smoking-cessation drugs reduce cigarette use, while ads for over-the-counter products do not. The research emphasizes the impact of advertising on public health goals for smoking cessation. Insurance coverage influences how ads affect behavior, with strong coverage leading to larger declines in cigarette sales. Ads for prescription products also boosted demand for alternative methods. The study highlights how the effectiveness of advertising depends on therapy accessibility and affordability. Policymakers should consider these findings when regulating pharmaceutical advertising. The research analyzed advertising effects on cigarette consumption, showing that a 10% reduction in ads leads to increased cigarette sales.